Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The ribosomal S6 kinase inhibitor BI-D1870 ameliorated experimental autoimmune encephalomyelitis in mice.
Decision-making under explicit risk is impaired in multiple sclerosis: relationships with ventricular width and disease disability.
Diffusivity signatures characterize trigeminal neuralgia associated with multiple sclerosis.
Effect of in-painting on cortical thickness measurements in multiple sclerosis: A large cohort study.
[Natalizumap can induce progressive multifocal leucoencephalopathy.]
Symptoms and Association with Health Outcomes in Relapsing-Remitting Multiple Sclerosis: Results of a US Patient Survey.
11C-Acetate PET Imaging in Patients with Multiple Sclerosis.
Emotional Intelligence (EI) of Patients with Multiple Sclerosis (MS).
An MRI review of acquired corpus callosum lesions.
Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis.
Neuromuscular electrical stimulation cycling exercise for persons with advanced multiple sclerosis.
Moving to fingolimod from natalizumab in multiple sclerosis-reply.
Correlations between serum uric Acid level and disease activity, intrathecal inflammation reactivity in patients with multiple sclerosis.
24S-hydroxycholesterol in plasma: A marker of cholesterol turnover in neurodegenerative diseases.
Comparison of two commercial ELISA systems for evaluating anti-EBNA1 IgG titers.
Multiple sclerosis. Recent modalities of treatment.
Rotating-polarization CARS microscopy: combining chemical and molecular orientation sensitivity.
A short and validated multiple sclerosis-specific health-related quality of life measurement for routine medical practice.
Oligoclonal band status in scandinavian multiple sclerosis patients is associated with specific genetic risk alleles.
Performance on Paced Auditory Serial Addition Test and cerebral blood flow in multiple sclerosis.
Respiratory muscle training for respiratory deficits in neurodegenerative disorders: a systematic review.
[Update on diagnosis and treatment of multiple sclerosis.]
Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis.
Structure-Kinetics Relationships - an overlooked parameter in hit-to-lead optimization: a case of cyclopentylamines as CCR2 antagonists.
Multiple sclerosis : A multielement survey.

Pages